Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis.


Journal

Annals of the American Thoracic Society
ISSN: 2325-6621
Titre abrégé: Ann Am Thorac Soc
Pays: United States
ID NLM: 101600811

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 3 10 2018
medline: 10 4 2020
entrez: 2 10 2018
Statut: ppublish

Résumé

Several randomized trials have compared the efficacy of an indwelling pleural catheter (IPC) versus the more traditional chemical pleurodesis in the management of malignant pleural effusion (MPE). As part of the American Thoracic Society's guidelines for management of MPE, we performed a systematic review and a meta-analysis to compare patient-centered outcomes with the use of a tunneled pleural catheter versus chemical pleurodesis for the first-line treatment of malignant pleural effusions. We performed literature searches in MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials. We included randomized controlled trials comparing IPC and pleurodesis in adult patients with symptomatic MPE. Risk of bias was assessed with the Cochrane Risk of Bias tool recommended by the Cochrane Methods Bias Group. The meta-analysis was performed with Review Manager software, using a random effects model. We used risk ratios (RRs) with 95% confidence interval (CI) as the effect measure for dichotomous outcomes and mean differences for continuous outcomes. We identified five randomized trials, involving 545 patients, that compared IPC and pleurodesis. Lack of blinding and the inevitable attrition of patients due to death resulted in an overall high risk of bias among the studies. No differences in survival or measures of dyspnea were observed in any of the studies. Total hospital length of stay was shorter, and repeat pleural interventions were less common in the IPC group (RR, 0.32; 95% CI, 0.18-0.55). However, the risk of cellulitis was higher with IPC (RR, 5.83; 95% CI, 1.56-21.8). No differences were noted in other adverse events. Compared with chemical pleurodesis, IPC results in shorter hospital length of stay and fewer repeat pleural procedures but carries a higher risk of cellulitis. Careful assessment of individual patient preferences and costs should be considered when choosing between IPC and pleurodesis.

Identifiants

pubmed: 30272486
doi: 10.1513/AnnalsATS.201807-495OC
doi:

Substances chimiques

Talc 14807-96-6

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

124-131

Commentaires et corrections

Type : CommentIn

Auteurs

Narayan P Iyer (NP)

1 Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, California.

Chakravarthy B Reddy (CB)

2 Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.

Momen M Wahidi (MM)

3 Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

Sandra Z Lewis (SZ)

4 Doctor Evidence, Santa Monica, California.

Rebecca L Diekemper (RL)

4 Doctor Evidence, Santa Monica, California.

David Feller-Kopman (D)

5 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Michael K Gould (MK)

6 Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California; and.

Alex A Balekian (AA)

7 Department of Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH